EPSTEIN-BARR VIRUS NUCLEAR ANTIGEN RECOMBINANT IMMUNOFLUORESCENT ASSAY— 510(k) K946353

Substantially Equivalent

Mrl Diagnostics

FDA 510(k) clearance K946353 for EPSTEIN-BARR VIRUS NUCLEAR ANTIGEN RECOMBINANT IMMUNOFLUORESCENT ASSAY, Substantially Equivalent on 1995-07-21. Applicant: Mrl Diagnostics.

Clearance details

Applicant: Mrl Diagnostics
Product code: Code LLM
Advisory panel: Microbiology
Date received: 1994-12-30
Decision date: 1995-07-21
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Cypress, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.